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Galactose:PEGamine coated gold nanoparticles
adhere to ﬁlopodia and cause extrinsic apoptosis†
Konstantina Tzelepi,a Cristina Espinosa Garcia,b Phil Williamsb and Jon Golding *a
Ultra-small gold nanoparticles, surface functionalised with a 50 : 50 ratio of a thiolated a-galactose derivative
and a thiolated hexaethylene glycol amine, are toxic to HSC-3 oral squamous carcinoma cells. Diﬀerences in
nanoparticle toxicity were found to be related to the synthesis duration, with 1 h reaction nanoparticles being
less toxic than 5 h reaction nanoparticles. The ligand density decreasedwith longer reaction time, although the
size, charge and ligand ratio remained similar. The concentration of sodium borohydride in the reaction
decreased logarithmically over 5 h but remained within a concentration range suﬃcient to desorb weakly
bound ligands, possibly explaining the observed gradual decrease in ligand density. Nanoparticle toxicity
was abrogated by inhibition of either caspase 3/7 or caspase 8, but not by inhibition of caspase 9,
consistent with extrinsic apoptosis. Electron microscopic analysis of cellular uptake demonstrated
predominantly cytoplasmic localization. However, when energy-dependent transport was inhibited, by
lowering the temperature to 4 C, a remarkable adhesion of nanoparticles to ﬁlopodia was observed.
Inhibition of ﬁlopodial assembly with a fascin inhibitor prevented nanoparticle adhesion to HSC-3 cells at
4 C, while fascin inhibition at 37 C resulted in less cytoplasmic uptake. More adhesion to HSC-3 ﬁlopodia
was seen with the higher toxicity 5 h reaction time nanoparticles than with the 1 h nanoparticles. By
including two further cell types (HaCaT keratinocytes and hCMEC/D3 endothelial cells), a pattern of
increasing toxicity with ﬁlopodial binding of 5 h reaction nanoparticles became apparent.
Introduction
Gold nanoparticles (AuNPs) hold enormous promise for deliv-
ering a variety of cargoes into cells. However, the details of how
diﬀerent AuNPs interact with and enter cells are still being
elucidated.1
Moreover, some AuNPs exhibit cytotoxicity that does not
always correlate directly with AuNP uptake.2–4 This cytotoxicity
can be useful when targeting cancer cells, but disastrous when
targeting delicate or diseased cells to improve their survival or
function. The physico-chemical parameters that can aﬀect
AuNP uptake and toxicity (without any targeting peptide or
antibody ligands) include: nanoparticle size,5 charge6 and the
nature and density of any coating polymers7–10 (reviewed by
Yah3). Exactly how nanoparticles damage cells remains unclear,
but can involve changes to biochemical stress signalling path-
ways11 and damage to organelles such as mitochondria, lyso-
somes, and DNA within the nucleus.12
We have previously shown that AuNPs coated with a 50 : 50
ratio of a-galactose : PEGamine ligands are eﬃciently taken up
into kidney and brain endothelial cells, predominantly by
energy-dependent mechanisms.13 These AuNPs show selective
toxicity toward HSC-3 skin cancer cells, compared to a normal
keratinocyte cell line (HaCaT) and this toxicity was caspase 3/7-
dependent and could be prevented by antioxidants.2
In order to examine the interaction and toxicity of a-gal-
actose:PEGamine AuNPs with HSC-3 cancer cells in more detail,
we analysed AuNP distribution on the cell surface, and within
the cytoplasm and nucleus. Two types of AuNPs were tested,
which diﬀered only in their synthesis time. One was reacted
with sodium borohydride for 1 h (short synthesis) and the other
was reacted for 5 h (long synthesis). We nd that the shorter
synthesis time AuNPs show less binding to lopodia and are
less toxic.
Materials and methods
Nanoparticle synthesis
2-Thioethyl a-D-galactopyranoside as the disulphide dimer (a-
galactose) and 1-thiohexaethylene glycol-17-ammonium acetate
(PEG-amine) (both from GalChimia, Spain) were mixed together
in a 50 : 50 molar ratio with HAuCl4 in Milli-Q water with a 3-
fold molar excess of total ligands to gold and adjusted to pH 12
with 2MNaOH. Themixture was stirred constantly and reduced
by adding NaBH4 to 90 mM and samples removed aer either
1 h or 5 h. AuNPs were then puried from unreacted ligands and
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reactants via ve rounds of spin washing with excess Milli-Q
water using an Amicon 10 kDa ultraltration device. AuNPs
were resuspended in water to 2 mg ml1 [Au] and stored in
amber vials at 4 C. Note that all AuNP concentrations stated in
this work are based on gold content.
Sodium borohydride assay
The hydrolytic loss of NaBH4 during the AuNP synthesis reac-
tion was monitored by the 2,4,6-trinitrobenzenesulfonic acid
(TNBS) assay.14 Milli-Q water was adjusted to pH 12 with 0.2 M
NaOH. To a 10 ml portion of this, NaBH4 was added to achieve
a nal concentration of 90 mM. To a 5 ml portion of the
resulting 90 mM NaBH4 solution, 15 mg HAuCl4 and 39 mg 5,5-
dithio-bis-(2-nitrobenzoic acid) were simultaneously added,
corresponding to the molarities of gold and ligands used in
a standard AuNP synthesis reaction (note that we had to replace
the a-galactose and PEG-amine disulphide ligands with another
disulphide, since TNBS reacts with primary amines). Twenty
microlitre aliquots of this reaction mixture were removed at
intervals and added to 180 ml of pH 12 water in 96-well plastic
plates. Finally, 20 ml aliquots of the diluted samples were added
to 200 ml aliquots of freshly prepared 2 mM TNBS in pH 12
water. Aer 15 min, the absorbance of the TNBS solution was
measured at 470 nm using a FLUOstar Optima plate reader
(BMG Labtech) and calibrated using a doubling dilution series
of the 90 mM NaBH4 solution, treated in an identical way to the
AuNP reaction.
Nanoparticle physico-chemical characterization
TEM. Samples were prepared by drop-coating lms of the
AuNP solutions on electrostatically discharged carbon-coated
copper TEM grids and visualized on a JEM-1400 model EM
instrument (JEOL, USA) operated at an accelerating voltage of 80
kV and 100 000 magnication. Core sizes were calculated
from TEM images using the automated particle analysis feature
of ImageJ soware and are reported as the mean and median
values.
DLS/zeta potential. The hydrodynamic diameter and charge
of AuNPs (500 mg ml1) were measured using a Zetasizer Nano
ZSP (Malvern instruments). DLS measurements were made
immediately in pH 7.4 PBS in a ZEN0040 cell, while zeta
potential measurements were made in 20 mM of phosphate
buﬀer at pH 7 in a DTS1070 cell.
UV-vis absorbance. Two hundred microlitres of 100–400 mg
ml1 AuNP solutions in water were measured against a water
blank in 96-well plates on a Labtech Spectrostar Nano spectro-
photometer. Absorbance was measured between 280 and
800 nm.
FPLC. 0.2 mg ml1 AuNPs were incubated in PBS for 30 min
at 37 C. Then 20 mg AuNPs were run on an AKTA Pure FPLC
system (GE Healthcare) with a Superdex 200 10/300 GL column
at 0.5 ml min1 isocratic in PBS, using a 100 ml injection loop
and the absorbance monitored at 400 nm.
1H-NMR. For each sample, 5 mg of AuNPs were transferred
into D2O using ultraltration (Amicon Ultra-4, MWCO 10 kDa).
Three centrifugation steps were performed in 2 ml D2O
(4700 rpm, 12 min). Aer the last centrifugation step, AuNPs
were transferred into Eppendorf tubes and dissolved with 0.3 M
KCN/0.1 M KOH in D2O at 37 C overnight. Samples were then
centrifuged at 13 000g for 1 min to remove any insoluble
material and analysed by 1H-NMR at 500 MHz (Avance III HD,
Bruker), using MestReNova soware. The dening protons for
the a-galactose and PEGamine ligands were identied to reso-
nate at 4.95 ppm and 2.75 ppm, respectively. These correspond
to the single anomeric proton of a-galactose (NMR doublet) and
the two CH2 protons proximal to the terminal NH2 group in the
PEG-amine linker (NMR triplet).
HPLC. To quantify thiol ligands, 8 ml of 0.5 mg ml1 AuNP
solution was mixed with 4 ml of 50 mM tris(2-carboxyethyl)
phosphine hydrochloride in water for 10 min at 37 C at
600 rpm. Then 28 ml of 25 mM Ellman's reagent in DMSO was
added and incubated for a further 60 min at 37 C at 600 rpm.
Samples were transferred to an HPLC vial and 10 ml of each
sample was injected into an Agilent 1260 Innity HPLC
machine with an Ascentis Express peptide ES-C18 column and
an acetonitrile/0.1% formic acid solvent gradient, with peak
detection at 330 nm. Pure ligands were similarly treated to
determine retention times. The HPLC was additionally tted
with an Agilent 6120 Single Quad mass spectrometer to verify
peak identities.
SEM-EDS. Three microlitres of 2 mg ml1 AuNP solutions
were dried onto aluminium stubs and analysed with a Zeiss
Supra 55VP Field Emission Gun Scanning Electron Microscope
(FEGSEM) at 20 kV. EDS analysis was performed with AZtec
Energy soware (Oxford Instruments). The stubs alone con-
tained undetectable levels of gold and sulphur, 4.9% carbon
and 0.5% oxygen. Weight% values for gold, sulphur, carbon and
oxygen in the AuNP samples were determined. The calculation
of the AuNP ligand density using the sulphur : gold (S : Au) ratio
is based on the assumption that each ligand on the AuNP
surface carries a single S atom, while Au atoms constitute the
AuNP core. The geometry of AuNPs is assumed to be spherical.
Cell culture
HSC-3 squamous carcinoma cells were purchased from the
American Type Culture Collection. HaCaT cells were a gi from
Erik Walbeem, Erasmus Medical Centre, Rotterdam. Cells were
cultured in low glucose (1 g l1) DMEM media (Gibco) supple-
mented with 10% FBS (Sigma-Aldrich) and 1% penicillin/
streptomycin in a humidied incubator at 37 C with 5% CO2.
Cells were grown in T-75 culture asks to about 80% conuency
before passage.
Clonogenic assay
Cells were seeded at 300 cells per well in 24-well plates and
allowed to adhere overnight. The next day, cells were exposed to
AuNPs for 3 h and then washed in fresh medium. We previously
demonstrated that 3 h incubation was optimal for clonogenic
assay and uptake studies using these types of sugar:PEGamine
AuNPs.2 Cells were le to grow for 6 days to form colonies and
were then stained and xed with 2% methylene blue in 50%
ethanol. Experiments were repeated three times, each with
808 | Nanoscale Adv., 2019, 1, 807–816 This journal is © The Royal Society of Chemistry 2019
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technical triplicates (total n ¼ 9). Images of stained plates were
captured using a G:Box Chemi XX6 gel documentation system
with GeneSys v1.4.6 soware (Syngene). Colonies containing
>50 cells were quantied using GeneTools v.4.03 soware
(Syngene) and expressed as percent of controls. Automated
counts were veried by eye. IC50 values were estimated from
logarithmic plots of AuNP concentration versus percent of
control colonies.
Cellular uptake and distribution
Cellular uptake was quantied by ICP-MS and TEM.
ICP-MS. Cells were seeded at 30 000 cells per well overnight in
24-well plates. At this density, most cells were isolated from their
neighbours. Cells were then incubated with AuNPs for 3 h at
a nal concentration of 10 mg ml1, in triplicate. Cells were
washed 3 times in medium, trypsinised and spin washed twice at
2000 rpm in 10 ml PBS. The number of cells in each sample was
counted using a haemocytometer prior to the nal spin and the
cell pellet was dissolved in 1 ml 2% nitric acid for 2 days. Samples
were analysed using a Perkin-Elmer NexION 300x ICP-MS with
NexION soware version 1.4. The gold amount was calculated
against a standard curve of gold chloride plus washed cells. The
amount of gold per cell was calculated for each sample by dividing
the measured gold amount by the cell number.
TEM. 100 000 cells per well were seeded onto 12-well trans-
well inserts overnight and then incubated with AuNPs for 3 h at
a concentration of 10 mg ml1. Experiments with HSC-3 cells
were repeated three times, each with technical duplicates (total
n ¼ 6). Experiments with HaCaT cells were technical triplicates.
Cells were xed and AuNPs were silver enhanced for 45 min at
room temperature (R-Gent, Aurion, Netherlands) and processed
for imaging according to Gromnicova.15 Ultrathin sections of
cells were visualized on a JEOL model 1010 EM instrument
operated at an accelerating voltage of 80 kV at 15 000 and
50 000 magnications. Only isolated cells were counted. It
should be noted that silver enhancement increases the size of
the nanoparticles, making them easier to detect in cell sections.
Nanoparticle TEM counts on cells
A systematic sampling method was used to evaluate nanoparticle
counts in cells. This method was based on acquiring 25 TEM
images at the same magnication and same settings across every
sample at regular intervals, which included every h eld of view
of a cell. Each image was loaded into ImageJ soware (NIH),
where the visible areas of the nucleus and cytoplasm, and the
length of the cell surface were measured, and the numbers of
nanoparticles in each of these three regions were manually
counted. Data are expressed as nanoparticles per micron2 for
nuclear and cytoplasmic nanoparticle counts, and as nano-
particles per micron for cell surface nanoparticle counts.
Fascin inhibition
The fascin inhibitor fascin-G2 (Xcessbio, M60269-2s) was used
to inhibit lopodia formation. Cells were incubated with 50 mM
fascin-G2 for 2 h at 37 C. Then cells were incubated with 10 mg
ml1 AuNPs in 50 mM fascin-G2 for a further 3 h, either at 37 C
or at 4 C. Cells were then washed, xed and prepared for TEM
analysis.
Caspase inhibition
Cells were set up for clonogenic assay as described. Cells were
pre-incubated with either 70 nM caspase 8 inhibitor I (Merck,
218773) or 50 nM caspase 9 inhibitor II (Merck, 218776) or
caspase 3/7 inhibitor (Abcam, ab120382) for 1 h prior to addi-
tion of 10 mg ml1 AuNPs and incubation for 3 h. 10 mM Anti-
mycin A (Abcam, ab141904) was used as a positive control for
apoptosis and 50 ng ml1 Apo2 ligand/TRAIL as a positive
control for inducing extrinsic apoptosis. Clonogenic assays were
analysed aer 6 days, as described. Experiments were repeated
three times, each with technical triplicates (total n ¼ 9).
Statistical analyses
Data were analysed using GraphPad 6.0 Prism soware. For cell
work, multiple comparisons between many groups were per-
formed by one-way ANOVA with Tukey's multiple comparison
post-test; while comparison of the mean values between two
groups was made by multiple two-tailed t-tests with a Sidak–
Bonferroni post-test. Comparison of S : Au ratios, O : Au ratios
and C : Au ratios were made using paired two-tailed t-tests.
Results and discussion
Physico-chemical and solution stability characterisation
TEM analysis revealed the short synthesis (1 h) and long
synthesis (5 h) AuNPs to be spherical with mean core diameters
of 1.6  0.8 nm and 1.5  0.9 nm, respectively (mean  SD; ESI
Fig. 1†). Consistent with this, the UV-vis spectra revealed no
plasmon band, indicating a core diameter smaller than 2 nm
(ref. 16) (ESI Fig. 2A†). DLS analysis showed a hydrodynamic
diameter of 4.6  0.9 nm for short synthesis AuNPs and 3.7 
1.0 nm for long synthesis AuNPs (mean  SD; ESI Fig. 2B†). The
zeta potential of the AuNPs at pH 7 was positive at 43.8 
16.4 mV for short synthesis AuNPs (with some split peaks) and
41.8  10.6 mV for long synthesis AuNPs (mean  SD; ESI
Fig. 2C†). FPLC revealed no tendency to aggregate in PBS, with
a single elution peak at 17.97 ml for short synthesis AuNPs and
at 17.99 ml for long synthesis AuNPs (ESI Fig. 2D†).
1H-NMR demonstrated an a-galactose : PEGamine ligand
ratio of 53 : 47 for short synthesis AuNPs and 51 : 49 for long
synthesis AuNPs (ESI Fig. 3†).
SEM-EDS analysis demonstrated a signicant 15%
decrease in the S : Au ratio from 0.1013  0.0011 for short
synthesis AuNPs to 0.0860  0.0018 for long synthesis AuNPs
(mean  SD, P ¼ 0.0001, n ¼ 5 areas analysed per sample; ESI
Fig. 4†), consistent with a loss of sulphur-bearing ligands. The
ratios of O : Au and C : Au in these analysed regions also
signicantly decreased with increasing AuNP synthesis time,
consistent with a loss of ligands (O : Au 0.1720  0.0035 for
short synthesis AuNPs to 0.1414  0.0025 for long synthesis
AuNPs; mean SD, P¼ 0.0001, n¼ 5. C : Au 0.3365 0.0091 for
short synthesis AuNPs to 0.2819  0.0114 for long synthesis
AuNPs; mean  SD, P ¼ 0.0006, n ¼ 5. ESI Fig. 4†).
This journal is © The Royal Society of Chemistry 2019 Nanoscale Adv., 2019, 1, 807–816 | 809
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HPLC analysis similarly demonstrated a loss of ligands from
the AuNPs with increasing reaction time (ESI Fig. 5†). Thus, short
synthesis AuNPs had 40.8 ligands per 100 Au atoms, while long
synthesis AuNPs had 34.8 ligands per 100 Au atoms (a decrease of
15%, consistent with SEM-EDS). A previous study has deter-
mined that 1.52 nm core diameter AuNPs contain an average of
116 Au atoms.17 This is within the size range of our AuNPs, as
determined by TEM. Therefore, the HPLC values of ligands per
100 Au atoms approximate the actual number of ligands per
AuNP. Interestingly, our data are similar to those of Jadzinsky
et al.,18 in which AuNPs comprising 102 gold atoms were found to
be surrounded by 44 thiol (p-mercaptobenzoic acid) ligands.
In agreement with our 1H-NMR data, the HPLC data
demonstrated that the a-galactose : PEGamine ligand ratio
remained stable during AuNP synthesis (53 : 47 for short
synthesis AuNPs and 52 : 48 for long synthesis AuNPs; ESI
Fig. 5†).
How are ligands being removed from AuNPs during
synthesis? Above a concentration of 24 mM, NaBH4 has been
shown to strip all ligands from readily formed >10 nm AuNPs
within 10min, while at lower NaBH4 concentrations, desorption
becomes less eﬀective (<30% desorption using 8 mM NaBH4
and no desorption using 0.5 mMNaBH4).19No similar study has
examined the kinetics of ligand desorption during AuNP
formation. Two ways in which NaBH4 could be quenched in the
reaction are via hydrolysis or reaction with disulphide bonds.
The former possibility is unlikely, since although NaBH4 is
hydrolysed within seconds at low pH, it is stable for days at high
pH and our reaction pH remains alkaline, falling from pH 12 to
pH 11.5 in 5 h. The second possibility is that a portion of the
NaBH4 is lost as it reduces the gold salt and the disulphide
bonds of the ligands. We therefore measured the NaBH4
concentration during AuNP synthesis and found that it
decreased logarithmically from 90 mM before adding the reac-
tants to 6 mM aer 5 h. Importantly, the NaBH4 concentration
fell below 24 mM within 35–40 min (ESI Fig. 6†). However, the
same reaction in the absence of disulphides did not demon-
strate any dramatic decrease in NaBH4 concentration for 5 h
(not shown). Thus, in our usual synthesis reaction, a low
concentration of NaBH4 persists in solution for several hours
and this could set up a dynamic equilibrium between ligand
desorption and resorption that favours a slow overall desorp-
tion of the more weakly bound ligands from the AuNPs.
Clonogenic assay
The cytotoxic/cytostatic potential of acute (3 h) exposure of HSC-
3 cells to AuNPs was determined by clonogenic assay and
showed a dose-dependent reduction in cell colonies. Short
synthesis AuNPs had an IC50 of around 8 mg ml
1, while long
synthesis AuNPs had an IC50 of around 3.5 mg ml
1 (Fig. 1).
Cellular uptake and distribution of AuNPs
Total cellular uptake of AuNPs, which includes AuNPs both on
and within cells, was determined by ICP-MS on low-density cell
cultures (to permit the unimpeded extension of lopodia
around each cell). Cells were found to accumulate similar
amounts of each type of AuNP within 3 h (4.8  1.8 pg per cell
for short synthesis AuNPs and 6.8  2.2 pg per cell for long
synthesis AuNPs; two-tailed t-test P ¼ 0.63).
To examine the details of AuNP cellular uptake, we used
a well-established quantitative TEM method.15,20–22 To discrim-
inate between energy-dependent and passive transport, cell
uptake studies were performed at 37 C or 4 C, respectively.
Following 3 h incubation at 37 C, AuNPs were found predom-
inantly within the cytoplasm, with no signicant diﬀerences
between the accumulation of short synthesis or long synthesis
AuNPs (Fig. 2), consistent with the ICP-MS data. However, when
incubated instead at 4 C, there was a dramatic shi in the
distribution of both AuNPs to the cell surface, with signicantly
more long synthesis AuNPs being associated with the cell
surface than short synthesis AuNPs (Fig. 3). At 4 C AuNPs were
not randomly distributed on the cell surface, but instead were
preferentially associated with lopodia (88.9% (3385/3808) of
long synthesis AuNPs and 82.5% (2254/2732) of short synthesis
AuNPs at the cell surface were associated with lopodia; Fig. 3B
and C).
Previous studies have shown that varying the ligand density
aﬀects nanoparticle cellular accumulation, although there is no
consensus on whether low or high ligand density is optimal.7–10
Moreover, the precise distribution of ligands on the nano-
particle surface may be crucial, since computer simulations
indicate that a homogeneous ligand distribution favours
cellular uptake, while the presence of ligand-free areas prevents
cellular uptake.23 However, in this study, AuNP intracellular
accumulation was not signicantly aﬀected by ligand density,
although binding to the cell surface was better with lower ligand
density AuNPs.
To conrm whether AuNPs were selectively binding to
lopodia, HSC-3 cells were pre-incubated with fascin-G2, an
inhibitor of the actin bundling ability of fascin, that thereby
destabilizes lopodia and prevents their formation. Fascin
inhibition resulted in 85% fewer lopodia per micron of
the cell surface (compare Fig. 4A and D with Fig. 4B, C, E
and F).
Following fascin inhibition, cells loaded with short synthesis
or long synthesis AuNPs at 4 C demonstrated a signicant
Fig. 1 Clonogenic assay of short synthesis (1 h) and long synthesis (5 h)
AuNPs on HSC-3 cells following 3 h acute exposure. All data are shown
as mean  SEM. ** ¼ P < 0.01, *** ¼ P < 0.001, n ¼ 9.
810 | Nanoscale Adv., 2019, 1, 807–816 This journal is © The Royal Society of Chemistry 2019
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Fig. 2 TEM images of silver enhanced HSC-3 cells after acute 3 h exposure to 10 mgml1 AuNPs at 37 C. (A) No AuNP control. (B) Short synthesis
(1 h) AuNPs. (C) Long synthesis (5 h) AuNPs. (B0) and (C0) showmagniﬁed portions of the boxed regions of (B) and (C), respectively. n¼ nucleus, cy
¼ cytoplasm, f¼ ﬁlopodia. Scale bars¼ 500 nm. (D) Quantitation of AuNP counts per micron2 for the nucleus and cytoplasm (left axis) and AuNP
counts per micron for the cell surface (right axis, bars with red border). Total numbers of AuNPs counted per category are shown on bars. All data
are shown as mean  SEM, n ¼ 6.
Fig. 3 TEM images of silver enhanced HSC-3 cells after acute 3 h exposure to 10 mg ml1 AuNPs at 4 C. (A) No AuNP control. (B) Short synthesis
(1 h) AuNPs. (C) Long synthesis (5 h) AuNPs. (B0) and (C0) showmagniﬁed portions of the boxed regions of (B) and (C), respectively. n¼ nucleus, cy
¼ cytoplasm, f¼ ﬁlopodia. Scale bars¼ 500 nm. (D) Quantitation of AuNP counts per micron2 for the nucleus and cytoplasm (left axis) and AuNP
counts per micron for the cell surface (right axis, bars with red border). Total numbers of AuNPs counted per category are shown on bars. All data
are shown as mean  SEM. * ¼ P < 0.05, n ¼ 6.
This journal is © The Royal Society of Chemistry 2019 Nanoscale Adv., 2019, 1, 807–816 | 811
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three-fold reduction of AuNPs at the cell surface (Fig. 4G), while
cells loaded with short synthesis or long synthesis AuNPs at
37 C demonstrated signicantly fewer AuNPs within the cyto-
plasm (Fig. 4H).
AuNP interactions with other cell lines
In order to determine if there were any obvious trends in the
way that long synthesis AuNPs interact with cell membranes, we
examined two additional cell types: hCMEC/D3 human endo-
thelial cells and HaCaT human keratinocytes.
First, we examined whether incubation at 4 C resulted in an
inhibition of cellular uptake and a redistribution of AuNPs to
the cell surface. As shown in Fig. 4, the uptake of 10 mg ml1
long synthesis AuNPs into HSC-3 cells is inhibited by 95% if the
incubation is performed at 4 C (mean cytoplasmic AuNPs: 5.97
 1.97/mm2 at 37 C versus 0.28  0.12/mm2 at 4 C, Fig. 4G
and H). The accumulation of 10 mg ml1 long synthesis AuNPs
into HaCaT cells was similarly inhibited by 94% when the
incubation was performed at 4 C (mean cytoplasmic AuNPs:
7.39  1.02/mm2 at 37 C versus 0.43  0.12/mm2 at 4 C; ESI
Fig. 7A and B†). Finally, under conditions comparable to those
used here, we previously reported that the accumulation of 8 mg
ml1 long synthesis AuNPs into hCMEC/D3 cells for 3 h is
inhibited by 98% if the incubation is instead performed at
4 C.13
Next, we focussed on the proportion of long synthesis AuNPs
associated with lopodia on the cell surface at 4 C. As
mentioned above, HSC-3 cells exhibit 88.9% association of
AuNPs with lopodia at 4 C (3385 AuNPs on lopodia of 3808
Fig. 4 (A–F) TEM images of silver enhanced HSC-3 cells incubated for 3 h with 10 mgml1 AuNPs at 4 C in (A) the absence or (B, C) the presence
of a fascin inhibitor or at 37 C in (D) the absence or (E, F) the presence of a fascin inhibitor. Scale bars ¼ 500 nm. (G, H) Quantitation of AuNP
counts per micron2 for the nucleus and cytoplasm (left axis) and AuNP counts per micron for the cell surface (right axis) with or without a fascin
inhibitor at either (G) 4 C or (H) 37 C. Total numbers of AuNPs counted per category are shown below bars. All data are shown as mean SEM. *
¼ P < 0.05, ** ¼ P < 0.01, n ¼ 6.
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total AuNPs on the cell surface). In contrast, HaCaT cells exhibit
52.5% association of AuNPs with lopodia at 4 C (519 AuNPs
on lopodia of 988 total AuNPs on the cell surface, ESI Fig. 7B†).
A novel re-analysis of our existing TEM data for hCMEC/D3 cells
at 4 C (ref. 13) showed 11.9% association of AuNPs with lo-
podia (78 AuNPs on lopodia of 657 total AuNPs on the cell
surface, ESI Fig. 7C and D†).
From this limited dataset, it is possible to see a trend whereby
the proportion of AuNPs associated with lopodia on the cell
surface correlates with toxicity. Thus, HSC-3: 88.9% lopodia
binding, IC50 3.5 mgml
1; HaCaT: 52.5%lopodia binding, IC50 10
mg ml1 (ESI Fig. 7E†); and hCMEC/D3: 11.9% lopodia binding,
IC50 > 75 mg ml
1 (note that hCMEC/D3 does not grow clono-
genically). However, AuNPs were non-toxic at 75 mg ml1 aer
continuous exposure for 48 h (ref. 13). These data suggest that
lopodial binding may stimulate cell death receptor(s), and this
possibility is further explored in the next section usingHSC-3 cells.
This is the rst unequivocal report of AuNPs interacting
specically with lopodia. On macrophages, bacterial particles
are captured by the sha of the lopodia and then directed
towards the cell surface into phagocytic cups.24 Similarly, exo-
some nanovesicles attach to lopodia and become directed to
endocytic hotspots at their base.25 AuNPs were only seen on
lopodia at 4 C when energy-dependent transport was inhibi-
ted; this suggests that at 37 C they are normally rapidly cleared
and/or endocytosed. However, we have no evidence that the
extent of lopodial binding is a predictor of subsequent uptake:
they could be independent.
We cannot yet denitively state whether AuNPs initially bind
to pre-existing lopodia or whether AuNP binding to the cell
surface locally stimulates lopodia formation. A study involving
silica nanoparticles found that the nanoparticle aspect ratio
aﬀected lopodia formation and pinocytosis.26
One possibility is that these AuNPs are capable of binding to
receptors expressed preferentially on lopodia, possibly in an
analogous manner to the selective cancer cell targeting of some
oncolytic viruses.27
Another possibility is that electrostatic interactions may
occur between the positively charged AuNPs and the negatively
charged cell membrane.28,29 Selectivity could arise due to vari-
ations in membrane potential, which can diﬀer by up to 90 mV
between diﬀerent cell types.28 It is currently unknown whether
the membrane potential of lopodia is more negative than that
of the other regions of the cell membrane. However, the
curvature of the lopodial sha is sculpted from within by
negative charges on the convex surface of small, ‘banana-sha-
ped’ intracellular proteins, which repel and bend the adjacent
negatively charged cell membrane.30 Speculatively, this may
locally increase the negative charge on the lopodia surface.
Consistent with this idea, positively charged 1.4 nm “Nanogold”
AuNPs appear to bind to lopodia more strongly than the rest of
the cell membrane on xed COS7 cells.31 Although the magni-
cation used in that SEM study was unable to resolve individual
AuNPs. The exact nature of the ligand shell on nanogold is
proprietary, but the manufacturer states there are 6 primary
amine groups per AuNP.32 This diﬀers from the ligand structure
of our AuNPs, disfavouring (but not disproving) the idea of
a common lopodial receptor for both types of AuNPs and
instead favouring the idea of an electrostatic contribution to
AuNP binding to cell surfaces, with the exact distribution of
AuNPs on each cell surface being determined by charge
heterogeneities.
Independent of AuNP charge, the energy-independent inser-
tion of AuNPs coated in amphiphilic organic ligands into the cell
membrane lipid bilayer occurs preferentially in regions of high
cellmembrane curvature33 and is dramatically improved when the
core size is below 3 nm.34 Although these studies did not specif-
ically examine lopodia, the tips and bases of lopodial protru-
sions and the small radius of the lopodial sha all constitute
highly curved regions of the cell membrane and could therefore
act as preferential adhesion sites for nanoparticles capable of this
kind of membrane insertion via ‘snorkeling’.35 In the present
study, the hexaethylene glycol portion of the PEGamine ligand
may be suﬃciently amphiphilic to allow such an energy-
independent interaction with the cell membrane. Further
detailed studies will be required to compare the lopodial
binding and cellular uptake of AuNPs using diﬀerent ratios of a-
galactose : PEGamine. Our previous study2 demonstrated diﬀer-
ences in uptake (assessed by ICP-MS) into HSC-3 and HaCaT cells
as the a-galactose : PEGamine ratio was varied. The highest
uptake being seen with 50 : 50 ratio AuNPs (50 : 50 > 60 : 40 z
40 : 60z 0 : 100 > 100 : 0). However, we do not yet have any TEM
data regarding the lopodial interactions of these diﬀerent a-
galactose : PEGamine ratio AuNPs under energy-independent
conditions, such as incubation at 4 C, and we have found no
similar TEM study in the literature.
AuNP toxicity is due to extrinsic apoptosis
These studies were done using the more toxic, long synthesis
AuNPs. Co-incubation of HSC-3 cells with AuNPs and a caspase
3/7 inhibitor prevented AuNP-induced cell death in clonogenic
assays, conrming apoptosis (Fig. 5A).
To discriminate between classical caspase-dependent
extrinsic and intrinsic apoptosis pathways, cells were co-
incubated with AuNPs and either a caspase 8 inhibitor (apical
caspase in the extrinsic pathway) (Fig. 5B) or a caspase 9
inhibitor (apical caspase in the intrinsic pathway) (Fig. 5C).36
Caspase 9 inhibition had no eﬀect on AuNP toxicity, while
caspase 8 inhibition prevented AuNP toxicity, suggesting
extrinsic apoptosis. In each case, cell death due to positive
control apoptosis-inducing agents was prevented by the caspase
inhibitors (Fig. 5). Note that each caspase inhibitor alone is
slightly toxic and rescue of AuNP or positive control drug
toxicity brings the cell viability back to the inhibitor-only value.
Nanoparticle toxicity,37 specically AuNP toxicity,38 is usually
reported to occur viamitochondrial37 or endoplasmic reticulum
stress,39 leading to cleavage of caspase 9.38,40 By contrast,
nanoparticle-induced extrinsic apoptosis, due to caspase 8
cleavage, is rarely reported. Cleavage of caspase 8 and accu-
mulation of FADD were seen in JB6 mouse skin cells within 1 h
of adding tungsten carbide–cobalt nanoparticles,41 while
cleavage of caspase 8 was seen in human keratinocyte HaCaT
cells within 6 h of adding titanium dioxide nanoparticles.42
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However, to our knowledge, extrinsic apoptosis has not been
reported before with AuNPs. We do not claim that there is
anything particularly unusual about our AuNPs that leads to
extrinsic apoptosis, simply that most papers demonstrating
AuNP-induced apoptosis only look at caspase 3 activation
(reviewed in ref. 38).
It is tempting to link our observations of increased lopodial
binding of AuNPs with extrinsic apoptosis. However, our data
do not yet allow us to conclude that excessive lopodial binding
causes apoptosis. Future work will determine whether these,
currently independent, observations are linked.
For instance, it is not known whether any of the death
receptors (TNFr, TRAMP, Fas, or DRs 4 to 6),43 which locally
cleave and activate caspase 8, are concentrated within lopodia
and could thereby become activated by excessive or prolonged
AuNP binding. It is nonetheless intriguing that increased lo-
podial density is oen reported in cancer cells,44 being impor-
tant for tumour progression, migration and dissemination.44,45
Moreover, caspase 8 is associated with cell migration in cancer
cells,46 being specically associated with focal adhesion
complexes,47 raising the possibility that caspase 8 may also be
concentrated within lopodia.
Once inside cells, AuNPs can damage or impair the function
of various organelles (reviewed in ref. 48), including lyso-
somes,49 mitochondria50 and the nucleus.12 AuNPs can also
activate metal exposure and oxidative stress signalling path-
ways,11 resulting in autophagy.51
AuNP-induced cell death is therefore likely to be multifac-
torial, with distinct temporal sequences of events converging via
several pathways to kill the cell.
Conclusions
We have identied that 50 : 50 a-galactose : PEGamine AuNPs
accumulate to diﬀering extents on the lopodia of various cell
types when energy-dependent uptake is prevented. These data
provide a fascinating insight into how AuNPs initially interact
with cell membranes and how the extent of lopodial interac-
tion may be a deciding factor in the initiation of extrinsic death
pathways. It will now be important to survey a large number of
normal and diseased cell types to determine whether there is
a correlation between how AuNPs interact with cell membranes
and resulting cell behaviours, not limited to cell death.
Nanoparticle synthesis time is rarely reported in the litera-
ture. Our observation that longer synthesis time AuNPs are
more adherent to HSC-3 cell membranes and are more toxic
than short synthesis AuNPs underscores that future publica-
tions would be wise to routinely quote synthesis time.
From a practical perspective, our data suggest that by varying
the synthesis time, AuNPs could be engineered for either enhanced
or reduced toxicity, depending on the desired application.
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